Who are Scilex Holding Co's main suppliers?

Scilex Holding Co (SCLXW) key suppliers include: Datavault AI Inc., ORANY, ORANY, Oramed Pharmaceuticals Inc., Oramed Pharmaceuticals Inc. and 7 more. View the full supplier network at chainsifter.com/chain/SCLXW.

Who are Scilex Holding Co's major customers?

Scilex Holding Co (SCLXW) key customers include: BNY-PK, BNY-PK, Datavault AI Inc., Datavault AI Inc., ORANY and 9 more. View the full customer network at chainsifter.com/chain/SCLXW.

What sector is Scilex Holding Co in?

Scilex Holding Co (SCLXW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Scilex Holding Co Suppliers, Customers & Supply Chain (SCLXW)

12Suppliers

14Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Scilex Holding Co (SCLXW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

28Total relationships

6Distinct source URLs

2High confidence

0.733Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Scilex Holding Co Suppliers

Ticker	Name	Confidence	Evidence
DVLT	Datavault AI Inc.	72%	Reciprocal relationship from DVLT graph: of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from SCLXW graph: cal companies in rapidly evolving fields, and we have not yet demonstrated an ability to overcome such risks and di…
ORANY	ORANY	72%	cal companies in rapidly evolving fields, and we have not yet demonstrated an ability to overcome such risks and difficulties successfully. Our ability to execute on our business model and generate r…
ORMP	Oramed Pharmaceuticals Inc.	72%	cal companies in rapidly evolving fields, and we have not yet demonstrated an ability to overcome such risks and difficulties successfully. Our ability to execute on our business model and generate r…
ORMP	Oramed Pharmaceuticals Inc.	72%	Reciprocal relationship from ORMP graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from ORMP…
SCLX	Scilex Holding Company	72%	Reciprocal relationship from SCLX graph: Reciprocal relationship from SCLXW graph: ts obligation assumed by Sorrento $ $ $ See accompanying notes to audited consolidated financial statements F- 7 SCI…
SCLX	Scilex Holding Company	72%	ts obligation assumed by Sorrento $ $ $ See accompanying notes to audited consolidated financial statements F- 7 SCILEX HOLDING COMPANY NOTES TO CONSOLIDATE D FINANCIAL STATEMENTS million receivable …
SMNR	Semnur Pharmaceuticals, Inc.	72%	Reciprocal relationship from SMNR graph: celled in exchange for shares of Common Stock and options to purchase Common Stock, F- 7 Table of Contents SEMNUR PHARMACEUTICALS, INC. NOTES TO CONDENSED CON…
SMNRW	SMNRW	72%	Reciprocal relationship from SMNRW graph: Reciprocal relationship from SCLXW graph: operations of our suppliers. If contamination or other quality defects are discovered in our supply of ZTlido, GLOP…
SMNRW	SMNRW	72%	operations of our suppliers. If contamination or other quality defects are discovered in our supply of ZTlido, GLOPERBA, ELYXYB or our product candidates or in the manufacturing facilities, such manu…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCLXW graph: result in significant delay or material additional costs. Under the Genzyme Supply Agreement, we depend on Genzyme …
SNYNF	Sanofi	72%	result in significant delay or material additional costs. Under the Genzyme Supply Agreement, we depend on Genzyme to fulfill our clinical and commercial supply requirements for sodium hyaluronate, o…

Scilex Holding Co Customers

Ticker	Name	Confidence	Evidence
BNY-PK	BNY-PK	72%	ny accounted for the Funding as an equity security under ASC 321 as it provides the Company with the right to acquire equity ownership in the future at a fixed price through the payment of the remain…
BNY-PK	BNY-PK	72%	Reciprocal relationship from BNY-PK graph: Reciprocal relationship from SCLXW graph: ny accounted for the Funding as an equity security under ASC 321 as it provides the Company with the right to acqu…
DVLT	Datavault AI Inc.	72%	ting and elected to apply the fair value option, with changes in the fair F- 34 shares of Datavault Common Stock for gross proceeds of $ million , which resulted in realized gains in the amount of $ …
DVLT	Datavault AI Inc.	72%	Reciprocal relationship from DVLT graph: department, 85 employees in our general and administrative department. None of our employees are represented by a labor union with respect to his or her emplo…
ORANY	ORANY	72%	o other available therapies. Health Technology Assessment (“HTA”) of medicinal products is becoming an increasingly common part of the pricing and reimbursement procedures in some EEA countries, incl…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from SCLXW graph: o other available therapies. Health Technology Assessment (“HTA”) of medicinal products is becoming an increasingly…
ORMP	Oramed Pharmaceuticals Inc.	72%	cal companies in rapidly evolving fields, and we have not yet demonstrated an ability to overcome such risks and difficulties successfully. Our ability to execute on our business model and generate r…
ORMP	Oramed Pharmaceuticals Inc.	72%	Reciprocal relationship from ORMP graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from ORMP…
SCLX	Scilex Holding Company	72%	Reciprocal relationship from SCLX graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from SCLX graph: Reciprocal relationship from SCLXW graph: ts obligation assumed by Sorrento…
SCLX	Scilex Holding Company	72%	ts obligation assumed by Sorrento $ $ $ See accompanying notes to audited consolidated financial statements F- 7 SCILEX HOLDING COMPANY NOTES TO CONSOLIDATE D FINANCIAL STATEMENTS million receivable …
SMNRW	SMNRW	72%	Reciprocal relationship from SMNRW graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from SMNRW graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from SM…
SMNRW	SMNRW	72%	operations of our suppliers. If contamination or other quality defects are discovered in our supply of ZTlido, GLOPERBA, ELYXYB or our product candidates or in the manufacturing facilities, such manu…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCLXW graph: o other available therapies. He…
SNYNF	Sanofi	72%	o other available therapies. Health Technology Assessment (“HTA”) of medicinal products is becoming an increasingly common part of the pricing and reimbursement procedures in some EEA countries, incl…

Scilex Holding Co Debt Obligations

Instrument	Description	Confidence	Evidence
SCLXW-DEBT-12418	Warrants outstanding: 36.4	90%	xbrl warrant detail from xbrl 2025-09-30.
SCLXW-DEBT-12419	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.

Scilex Holding Co Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Scilex Holding Co.

Scilex Holding Co Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Scilex Holding Co.

Scilex Holding Co Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['customer', 'supplier']
SMNRW	Semnur Pharmaceuticals, Inc.	100.00	1	['customer', 'supplier']
BNY-PK	Bank of New York Mellon Corp	100.00	1	['customer']
DVLT	Datavault AI Inc.	100.00	1	['customer', 'supplier']
SMNR	Semnur Pharmaceuticals, Inc.	100.00	1	['supplier']
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
AKO-B	ANDINA BOTTLING CO INC	50.00	2

Scilex Holding Co Supply Chain